Merck KGaA to buy cancer biotech SpringWorks for $3.9 billion

German firm boosts its US position and adds oncology drugs and pipeline to health-care business

Apr 28, 2025 - 21:55
 0
Merck KGaA to buy cancer biotech SpringWorks for $3.9 billion
German firm boosts its US position and adds oncology drugs and pipeline to health-care business